Synovus Financial Corp Baxter International Inc Transaction History

Synovus Financial Corp

  • $8.56 Billion
  • Q3 2024

A detailed history of Synovus Financial Corp transactions in Baxter International Inc stock. As of the latest transaction made, Synovus Financial Corp holds 25,302 shares of BAX stock, worth $746,409. This represents 0.01% of its overall portfolio holdings.

Number of Shares
25,302
Previous 25,302 -0.0%
Holding current value
$746,409
Previous $960,000 -0.0%
% of portfolio
0.01%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$32.85 - $40.26 $232,150 - $284,517
-7,067 Reduced 21.83%
25,302 $960,000
Q2 2024

Aug 13, 2024
SELL
$32.87 - $43.55 $47,036 - $62,320
-1,431 Reduced 4.23%
32,369 $1.08 Million
Q1 2024

May 14, 2024
SELL
$37.88 - $43.77 $1.75 Million - $2.02 Million
-46,245 Reduced 57.77%
33,800 $1.44 Million
Q3 2023

Nov 13, 2023
SELL
$37.32 - $49.29 $186,898 - $246,844
-5,008 Reduced 5.89%
80,045 $3.02 Million
Q2 2023

Aug 08, 2023
BUY
$39.98 - $47.68 $53,213 - $63,462
1,331 Added 1.59%
85,053 $3.88 Million
Q1 2023

May 11, 2023
SELL
$37.58 - $52.57 $1 Million - $1.41 Million
-26,740 Reduced 24.21%
83,722 $3.4 Million
Q4 2022

Feb 06, 2023
SELL
$49.7 - $57.71 $763,441 - $886,483
-15,361 Reduced 12.21%
110,462 $5.63 Million
Q3 2022

Oct 27, 2022
SELL
$53.86 - $66.8 $193,303 - $239,745
-3,589 Reduced 2.77%
125,823 $6.78 Million
Q2 2022

Aug 10, 2022
SELL
$63.83 - $80.0 $133,468 - $167,280
-2,091 Reduced 1.59%
129,412 $8.31 Million
Q1 2022

May 12, 2022
SELL
$76.85 - $89.45 $478,621 - $557,094
-6,228 Reduced 4.52%
131,503 $10.2 Million
Q4 2021

Feb 14, 2022
SELL
$74.57 - $87.19 $385,377 - $450,597
-5,168 Reduced 3.62%
137,731 $11.8 Million
Q3 2021

Nov 08, 2021
SELL
$73.77 - $83.61 $1.2 Million - $1.37 Million
-16,326 Reduced 10.25%
142,899 $11.5 Million
Q2 2021

Aug 11, 2021
SELL
$80.5 - $88.01 $2.27 Million - $2.48 Million
-28,153 Reduced 15.02%
159,225 $12.8 Million
Q1 2021

May 11, 2021
BUY
$76.38 - $86.03 $62,707 - $70,630
821 Added 0.44%
187,378 $15.8 Million
Q4 2020

Feb 11, 2021
BUY
$75.39 - $82.36 $643,905 - $703,436
8,541 Added 4.8%
186,557 $15 Million
Q3 2020

Nov 09, 2020
SELL
$78.33 - $90.73 $1.12 Million - $1.3 Million
-14,286 Reduced 7.43%
178,016 $14.3 Million
Q2 2020

Aug 10, 2020
SELL
$78.66 - $94.14 $5.04 Million - $6.03 Million
-64,010 Reduced 24.97%
192,302 $16.6 Million
Q1 2020

Apr 24, 2020
BUY
$71.57 - $93.3 $4.62 Million - $6.03 Million
64,595 Added 33.69%
256,312 $20.8 Million
Q4 2019

Feb 06, 2020
SELL
$76.7 - $88.45 $193,667 - $223,336
-2,525 Reduced 1.3%
191,717 $16 Million
Q3 2019

Nov 01, 2019
SELL
$81.4 - $89.78 $130,077 - $143,468
-1,598 Reduced 0.82%
194,242 $17 Million
Q2 2019

Aug 08, 2019
SELL
$73.44 - $82.41 $1.13 Million - $1.27 Million
-15,422 Reduced 7.3%
195,840 $16 Million
Q1 2019

May 09, 2019
SELL
$64.48 - $81.31 $39,074 - $49,273
-606 Reduced 0.29%
211,262 $17.1 Million
Q4 2018

Feb 07, 2019
BUY
$61.45 - $77.8 $654,626 - $828,803
10,653 Added 5.29%
211,868 $14 Million
Q3 2018

Nov 01, 2018
SELL
$70.71 - $77.75 $654,350 - $719,498
-9,254 Reduced 4.4%
201,215 $15.5 Million
Q2 2018

Aug 01, 2018
BUY
$63.43 - $75.41 $96,286 - $114,472
1,518 Added 0.73%
210,469 $15.5 Million
Q1 2018

May 07, 2018
SELL
$62.56 - $72.26 $53,050 - $61,276
-848 Reduced 0.4%
208,951 $13.6 Million
Q4 2017

Feb 09, 2018
BUY
$61.45 - $66.05 $171,384 - $184,213
2,789 Added 1.35%
209,799 $13.5 Million
Q3 2017

Nov 13, 2017
BUY
$59.5 - $64.61 $12.3 Million - $13.4 Million
207,010
207,010 $13 Million

Others Institutions Holding BAX

# of Institutions
1,007
Shares Held
450M
Call Options Held
2.79M
Put Options Held
2.44M
View Full List

About BAXTER INTERNATIONAL INC

BAX Quotes by TradingView
  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $14.9B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Synovus Financial Corp Portfolio

Follow Synovus Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Synovus Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email